BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17070161)

  • 1. Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction.
    Estensen ME; Hognestad A; Syversen U; Squire I; Ng L; Kjekshus J; Dickstein K; Omland T
    Am Heart J; 2006 Nov; 152(5):927.e1-6. PubMed ID: 17070161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial.
    Anker SD; Voors A; Okonko D; Clark AL; James MK; von Haehling S; Kjekshus J; Ponikowski P; Dickstein K;
    Eur Heart J; 2009 Jun; 30(11):1331-9. PubMed ID: 19383732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan.
    Belonje AM; Westenbrink BD; Voors AA; von Haehling S; Ponikowski P; Anker SD; van Veldhuisen DJ; Dickstein K
    Am Heart J; 2009 Jan; 157(1):91-6. PubMed ID: 19081402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; O'Brien RJ; Struck J; Quinn P; Morgenthaler N; Squire I; Davies J; Bergmann A; Ng LL
    J Am Coll Cardiol; 2007 Apr; 49(14):1525-32. PubMed ID: 17418290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
    Jansson AM; Aukrust P; Ueland T; Smith C; Omland T; Hartford M; Caidahl K
    Circulation; 2009 Jun; 119(25):3181-8. PubMed ID: 19528340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure.
    Dieplinger B; Gegenhuber A; Struck J; Poelz W; Langsteger W; Haltmayer M; Mueller T
    Clin Chim Acta; 2009 Feb; 400(1-2):91-6. PubMed ID: 19000665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure.
    Rumsfeld JS; Jones PG; Whooley MA; Sullivan MD; Pitt B; Weintraub WS; Spertus JA
    Am Heart J; 2005 Nov; 150(5):961-7. PubMed ID: 16290972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.
    Lewis EF; Velazquez EJ; Solomon SD; Hellkamp AS; McMurray JJ; Mathias J; Rouleau JL; Maggioni AP; Swedberg K; Kober L; White H; Dalby AJ; Francis GS; Zannad F; Califf RM; Pfeffer MA
    Eur Heart J; 2008 Mar; 29(6):748-56. PubMed ID: 18308687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein and heart failure after myocardial infarction in the community.
    Bursi F; Weston SA; Killian JM; Gabriel SE; Jacobsen SJ; Roger VL
    Am J Med; 2007 Jul; 120(7):616-22. PubMed ID: 17602936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients.
    Ueland T; Kjekshus J; Frøland SS; Omland T; Squire IB; Gullestad L; Dickstein K; Aukrust P
    J Am Coll Cardiol; 2005 Dec; 46(11):2018-21. PubMed ID: 16325035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
    Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction.
    Ueland T; Jemtland R; Godang K; Kjekshus J; Hognestad A; Omland T; Squire IB; Gullestad L; Bollerslev J; Dickstein K; Aukrust P
    J Am Coll Cardiol; 2004 Nov; 44(10):1970-6. PubMed ID: 15542278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.
    Korse CM; Taal BG; de Groot CA; Bakker RH; Bonfrer JM
    J Clin Oncol; 2009 Sep; 27(26):4293-9. PubMed ID: 19667278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction.
    Palmer BR; Pilbrow AP; Frampton CM; Yandle TG; Skelton L; Nicholls MG; Richards AM
    Eur Heart J; 2008 Oct; 29(20):2489-96. PubMed ID: 18757359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predischarge QRS score and risk for heart failure after first ST-elevation myocardial infarction.
    Kalogeropoulos AP; Chiladakis JA; Sihlimiris I; Koutsogiannis N; Alexopoulos D
    J Card Fail; 2008 Apr; 14(3):225-31. PubMed ID: 18381186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
    J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
    Rothenbacher D; Koenig W; Brenner H
    Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.
    Kelly D; Squire IB; Khan SQ; Quinn P; Struck J; Morgenthaler NG; Davies JE; Ng LL
    J Card Fail; 2008 Nov; 14(9):739-45. PubMed ID: 18995178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.